• The Latest Updated Products
  • Home > Product Partnering > The Latest Updated Products
Basic Search Search

Displaying 1 of 9 results per page Prev Next

The Latest Updated Products 게시물 리스트
product_code originator Lab Code or BRAND NAME API Action mechanism Indication Latest development stage Details
 PP120405009251   Ipsen Pharma(since Mar 2023), Albireo AB   Bylvay, A4250   odevixibat   A potent a..   Progressiv..   Approved, Phase III, Phase III    View Details 
 PP121129010518   Janssen Research & Development LLC, a J&J (since 2012), J&J PHARMACEUTICAL R&D, L.L.C., a J&J   Sirturo, TMC207, R207910   bedaquiline   An adenosi..   Tuberculos..   Approved, Phase III    View Details 
 PP130715011539   Astex Pharmaceuticals, Inc.   Balversa, JNJ-42756493, JNJ-493   erdafitinib   A Fibrobla..   Urogenital..   Approved, Phase III, Phase II    View Details 
 PP140324012069   Nanobiotix   NBTXR3, JNJ-1900   hafnium oxide, HfO2 crystals.   A free rad..   Head and n..   Phase III, Phase II, Phase III completed, Phase II completed    View Details 
 PP140702012215   Ambrx, Inc.   ARX788, JNJ-0683      Targeting ..   HER2+ brea..   Phase II, Phase II    View Details 
 PP141205012628   Istesso Ltd, Modern Biosciences plc   MBS2320, JNJ-7752   leramistat   Selectivel..   Rheumatoid..   Phase II, Phase I completed    View Details 
 PP160104013721   Neuroderm, Ltd., a Mitsubishi Tanabe Pharma   Onerji, ND0612H   levodopa and carbidopa   Levodopa c..   Severe Par..   Approved    View Details 
 PP181221016912   Janssen Pharmaceuticals, Inc., a J&J   MIN-202, JNJ-42847922, JNJ-7922   seltorexant HCl   A selectiv..   Insomnia a..   Phase III, Phase II    View Details 
 PP200522018144   Biogen Inc.   TMS-007, BIIB131, JX10      A plasmino..   Acute isch..   Phase III    View Details 
 PP210429018602   Luzsana Biotechnology, Inc.(since May 2022), HengRui USA, a Jiangsu Hengrui Medicine   AiRuiKa, SHR-1210   camrelizumab   A programm..   Hodgkin ly..   Approved, NDA    View Details